WeiJing
School
School of Pharmaceutical Science and Technology
Professional Title
Lecturer
Administrative Appointments
lecturer
Discipline
Pharmaceutical Information and Design
Contact Information
13920374842
betty_wj@tju.edu.cn
School of Pharmaceutical Science and Technology, Tianjin University
Education Background
- Doctoral degree| Tianjin University| School of Pharmaceutical Science and Technology| 2007
- Master’s Degree| Tianjin University| School of Computer Science and Technology| 2004
- Bachelor’s Degree| Tianjin Medical University| School of Public Health| 1995
Research Interests
- 1、Mechanism of action of antiviral drugs and related drug design
Positions & Employments
-
2004.6-2019.12
School of Pharmaceutical Science and Technology | Tianjin University | lecturer 
Academic Achievements
- Papers
- [1] [Advances in the study of A2B adenosine receptor antagonists].
- [2] Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design
-
- [3] Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)
- [4] Molecular docking and pharmacophore model studies of Rho kinase inhibitors
- [5] Molecular Mechanism of the Affinity Interactions Between BAFF and Its Peptides by Molecular Simulations
- [6] 3D Pharmacophore Based Virtual Screening of A(2A) Adenosine Receptor Antagonists
- [7] 3D pharmacophore models for thromboxane A(2) receptor antagonists
- [8] 3D-pharmacophore model for RXR gamma agonists
- [9] A Comparison of Biological Activity of B Lymphocyte Stimulator (BLyS) Antagonist Peptibodies and the Elucidation of Possible BLyS Binding Sites
- [10] Computer-aided de novo ligand design and docking/molecular dynamics study of Vitamin D receptor agonists
- [11] Computational studies of the binding modes of CCR1 antagonists
- [12] 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design
- [13] Identification of ligand binding site on RXR gamma using molecular docking and dynamics methods
- [14] Homology Modeling and Antagonist Binding Site Study of the Human Histamine H2 Receptor
- [15] Some insights into the binding mechanism of Aurora B kinase gained by molecular dynamics simulation
- [16] Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335
- [17] Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein
- [18] The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS-TACI interaction
- [19] 3D-Pharmacophere Models for CC Chemokine Receptor 1 Antagonists
- [20] A three-dimensional pharmacophore model for RXR alpha agonists
- [21] 3D-pharmacophore models for selective A(2A) and A(2B) adenosine receptor antagonists
- [22] Computational studies of the binding modes of A(2A) adenosine receptor antagonists
- Books
- [1] The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS–TACI interaction. Int. Immunopharmacol. 2015, 24 (2) 219–223.
- [2] Computer-aided de novo ligand design and docking/molecular dynamics study of Vitamin D receptor agonists. J. Mol. Model., 2012, 18(1): 203–212.